$210.00 – $750.00
Buy Opana Online-30mg & 40mg
Available Dosages: 30 mg & 40 mg
Imprints: “E” “30” & “E” “40”
Shape/Color: Round Concave Red/Yellow Tablets
Manufacturer: Endo labs.
USA: 4 to 24 hours
Canada: 1 to 2 Days
International Delivery: 3 to 4 Days
To treat your moderate to severe pain
Buy Opana Online
Geena online Pharmacy is the Best Online Pharmacy which patients can Order Opana Online . OPANA ER is an opioid agonist indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.
OPANA ER (oxymorphone hydrochloride) extended-release, is a semi-synthetic opioid analgesic supplied in 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg, 30 mg, and 40 mg tablet strengths for oral administration. The tablet strength describes the amount of oxymorphone hydrochloride per tablet. The 7.5 mg tablets contain iron Page 2 oxide black, and iron oxide yellow. The 10 mg tablets contain FD&C yellow No. 6. The 20 mg tablets contain FD&C blue No. 1, FD&C yellow No. 6, and D&C yellow No. 10. The 40 mg tablets contain FD&C yellow No. 6, D&C yellow No. 10, and lactose monohydrate. The molecular weight of oxymorphone hydrochloride is 337.80. The pKa1 and pKa2 of oxymorphone at 37°C are 8.17 and 9.54, respectively. The octanol/aqueous partition coefficient at 37°C and pH 7.4 is 0.98.
Order Opana Online
Buy Opana at Geena online Pharmacy and understand that OPANA ER is Administered on an empty stomach, at least 1 or 2 hours before eating. Symmetrical, every 12h dosing is appropriate for the majority of patients.
(DOSAGE AND ADMINISTRATION)
Opioid-Naïve Patients: Initiate treatment with 5 mg every 12 hours.
Opioid-Experienced Patients: Ratios as a guide to convert only from other opioids to OPANA ER.
Individualize treatment; titrate to effective and tolerable dose.
Don’t stop abruptly taper gradually to stop treatment . You can Order Opana Online now from Geena online Pharmacy.
shallow breathing, slow heartbeat;
cold, clammy skin;
severe weakness or dizziness; or
feeling light-headed, fainting.
Significant respiratory depression
Acute or severe bronchial asthma in an unmonitored setting or in absence of resuscitative equipment
Hypersensitivity to oxymorphone
Moderate or severe hepatic impairment
Known or suspected gastrointestinal obstruction, including paralytic ileus